China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...
Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense of RMB330 million. Major operating and financing activities generated RMB320 million cash inflows ...
Zacks Investment Research on MSN6h
Merck Loses Almost $52B in 6 Months: How to Play MRK StockThe stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous ...
TipRanks on MSN7h
Jacobio Pharmaceuticals Advances Cancer Drug Pipeline with Strategic Licensing and TrialsJacobio Pharmaceuticals Group Co., Ltd. ( ($HK:1167) ) has issued an announcement. Jacobio Pharmaceuticals has announced significant progress in ...
"Straight man cancer" describes the outspoken misogyny and entitlement of many men (and some women) in China. References to this "disease" first appeared on Weibo and Douban in June 2014 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback